Table 1.
Patient Characteristics, Serum Biomarkers, and Outcome Measures
| Parameters | Men (n = 6) | Women (n = 8) | Total (n = 14) | |
|---|---|---|---|---|
| Patient Characteristics | Age (years) | 60.65 (31.6, 73.8) | 68.65 (46.1, 79.6) | 66.5 (31.6, 79.6) |
| BMI (kg/m2) | 26.25 (21.4, 29.1) | 26.4 (24.1, 33.4) | 26.3 (21.4, 33.4) | |
| Height (cm) | 174.95 (162.6, 193) | 161.65 (152.4, 170.2) | 163.85 (152.4, 193) | |
| Follow-up (months) | 28.5 (0.7, 49.6) | 48.3 (18.1, 77.4) | 34.0 (0.7, 77.4) | |
| Primary Tumor Site | 4 Extremity; 1 GI; 1 Trunk | 1 Extremity; 3 GI; 4 Trunk | 5 Extremity; 4 GI; 5 Trunk | |
| Blood Serum Biomarkers | CRP (mg/L) | 0.2 (0.1, 0.5) | 0.44 (0.1, 10.4) | 0.28 (0.1, 10.4) |
| Creatinine (mg/dL) | 0.85 (0.7, 1) | 1 (0.6, 1.6) | 0.9 (0.6, 1.6) | |
| Hemoglobin (g/dL) | 13.9 (8.4, 14.6) | 11.95 (8.3, 14.2) | 13.4 (8.3, 14.6) | |
| Albumin (g/dL) | 4 (3, 4.6) | 3.7 (3.2, 4) | 3.75 (3, 4.6) | |
| Survival Statistics | OS (months) | 28.5 (0.7, 49.6) | 48.3 (18.1, 77.4) | 34 (0.7, 77.4) |
| LRFS (months) | 28.5 (0.7, 49.6) | 48.3 (15.5, 77.4) | 34 (0.7, 77.4) | |
| Other Outcomes | DCR (# of patients) | 3 patients | 3 patients | 6 patients |
| MSC (# of patients) | 2 patients | 2 patients | 4 patients |
Data presented is the median with the range in parentheses.
Abbreviations: BMI, Body mass index; GI, Gastrointestinal; CRP, C-reactive protein; OS, Overall survival; LRFS, Local recurrence-free survival; DCR, Distant cancer recurrence; MSC, Major surgical complications.